Should Oklahoma screen newborns for galactosemia?
D003362:Cost-Benefit Analysis; D005693:Galactosemias / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening / Q000191:economics; D009825:Oklahoma